{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:41:56Z","timestamp":1776919316422,"version":"3.51.2"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T00:00:00Z","timestamp":1439769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.redox.2015.08.014","type":"journal-article","created":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T00:04:21Z","timestamp":1440029061000},"page":"318-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling"],"prefix":"10.1016","volume":"6","author":[{"given":"Federica","family":"Vannini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitali","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravinder","family":"Kodela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen P.N.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4060-7283","authenticated-orcid":false,"given":"Khosrow","family":"Kashfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2015.08.014_bib1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2015.08.014_bib2","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2015.08.014_bib3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","article-title":"A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer","volume":"348","author":"Sandler","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2015.08.014_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1054-3589(08)57002-5","article-title":"Anti-inflammatory agents as cancer therapeutics","volume":"57","author":"Kashfi","year":"2009","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.014_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1021\/ml300002m","article-title":"NOSH-Aspirin: A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals","volume":"3","author":"Kodela","year":"2012","journal-title":"ACS Med Chem Lett."},{"key":"10.1016\/j.redox.2015.08.014_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.niox.2014.05.014","article-title":"Hydrogen sulfide and nitric oxide interactions in inflammation","volume":"41","author":"Lo Faro","year":"2014","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.redox.2015.08.014_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/gast.2000.9304","article-title":"Nitric oxide in mucosal defense: a little goes a long way","volume":"119","author":"Wallace","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2015.08.014_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000201277","article-title":"Healing of chronic gastric ulcerations by l-arginine. Role of nitric oxide, prostaglandins, gastrin and polyamines","volume":"56","author":"Brzozowski","year":"1995","journal-title":"Digestion"},{"key":"10.1016\/j.redox.2015.08.014_bib9","doi-asserted-by":"crossref","first-page":"G341","DOI":"10.1152\/ajpgi.2000.279.2.G341","article-title":"Endothelial nitric oxide synthase modulates gastric ulcer healing in rats","volume":"279","author":"Ma","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.redox.2015.08.014_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.gtc.2009.03.001","article-title":"Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the future","volume":"38","author":"Fiorucci","year":"2009","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"10.1016\/j.redox.2015.08.014_bib11","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/j.gastro.2005.07.060","article-title":"Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs","volume":"129","author":"Fiorucci","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2015.08.014_bib12","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1096\/fj.07-8669com","article-title":"Hydrogen sulfide enhances ulcer healing in rats","volume":"21","author":"Wallace","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.redox.2015.08.014_bib13","doi-asserted-by":"crossref","first-page":"S-596","DOI":"10.1016\/S0016-5085(13)62197-6","volume":"144","author":"Nia","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2015.08.014_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbrc.2012.02.051","article-title":"NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model","volume":"419","author":"Chattopadhyay","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2015.08.014_bib15","doi-asserted-by":"crossref","unstructured":"F. Vannini, A.C. MacKessack-Leitch, E.K. Eschbach, M. Chattopadhyay, R. Kodela, K. Kashfi, Synthesis and anti-cancer potential of the positional isomers of NOSH-aspirin (NBS-1120) a dual nitric oxide and hydrogen sulfide releasing hybrid. Bioorg Med Chem Lett 2015;(in press) 10.1016\/j.bmcl.2015.08.023","DOI":"10.1016\/j.bmcl.2015.08.023"},{"key":"10.1016\/j.redox.2015.08.014_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0006-2952(96)00181-5","article-title":"Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway","volume":"52","author":"Hanif","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.014_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1124\/jpet.112.201970","article-title":"Positional isomers of aspirin are equally potent in inhibiting colon cancer cell growth: differences in mode of cyclooxygenase inhibition","volume":"345","author":"Kodela","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.redox.2015.08.014_bib18","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1074\/jbc.M113.517987","article-title":"Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network","volume":"289","author":"Xu","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2015.08.014_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.niox.2014.12.009","article-title":"On the chemical biology of the nitrite\/sulfide interaction","volume":"46","author":"Cortese-Krott","year":"2015","journal-title":"Nitric oxide: Biol. Chem."},{"key":"10.1016\/j.redox.2015.08.014_bib20","doi-asserted-by":"crossref","first-page":"12016","DOI":"10.1021\/ja3009693","article-title":"Chemical characterization of the smallest S-nitrosothiol, HSNO; cellular cross-talk of H2S and S-nitrosothiols","volume":"134","author":"Filipovic","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.redox.2015.08.014_bib21","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1016\/S0021-9258(18)53294-4","article-title":"Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs","volume":"268","author":"Meade","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2015.08.014_bib22","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1139\/y97-130","article-title":"Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays","volume":"75","author":"Riendeau","year":"1997","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.014_bib23","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.112.201970","article-title":"Positional isomers of aspirin are equally potent in inhibiting colon cancer cell growth: Differences in mode of cyclooxygenase inhibition","author":"Kodela","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.redox.2015.08.014_bib24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nsb0895-637","article-title":"The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase","volume":"2","author":"Loll","year":"1995","journal-title":"Nat. Struct. Biol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231715001044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231715001044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:00:00Z","timestamp":1761976800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231715001044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":24,"alternative-id":["S2213231715001044"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2015.08.014","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2015.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}